Key result
Dabigatran treatment at therapeutic levels impacts point-of-care international normalized ratio (INR) measurements.
Key points are not available for this paper at this time.
May require lab confirmation of point-of-care INR on dabigatran; leaves open clinical impact and device validation needs.
Article Effect of dabigatran treatment at therapeutic levels on point-of-care international normalized ratio (INR) was published on July 1, 2017 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 55, issue 7).
No takes yet. Share an insight, caveat, or question.
Løkkebø et al. (2016) studied this question. Dabigatran treatment at therapeutic levels impacts point-of-care international normalized ratio (INR) measurements.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: